From CE Mark to UAE Approval: How Pure Global Streamlines Your Medical Device Registration Documents for MoHAP

The United Arab Emirates is a key expansion target for many MedTech companies, but its regulatory environment is notoriously strict. This episode provides a detailed guide to the essential documents required for medical device registration with the UAE's Ministry of Health and Prevention (MoHAP), moving beyond a simple checklist to offer strategic insights. We break down the critical importance of prior authorization from a reference country, the nuances of technical file preparation, and the often-underestimated legal paperwork that can lead to immediate rejection. Learn how to prepare a submission dossier that meets MoHAP's high standards and avoid the common pitfalls that delay market access. A European MedTech company with a valid CE mark faced a six-month delay and thousands in unexpected costs trying to enter the UAE market. Their failure wasn't due to the device's quality, but because their labeling wasn't in Arabic and their legal documents lacked the correct multi-step attestation required by the UAE authorities, leading to an outright rejection of their initial submission. Key Takeaways: 1. Why is a Certificate of Free Sale from a reference country non-negotiable for UAE market entry? 2. What specific ISO certifications must be included in your submission dossier? 3. Are English-only Instructions for Use (IFU) and labels sufficient for MoHAP approval? 4. What is the multi-stage "legalization" process for documents like the Power of Attorney, and why does it cause so many rejections? 5. How does appointing a local UAE Authorized Representative impact your application? 6. Beyond clinical data, what specific post-market surveillance information does MoHAP expect? 7. What are the most common, easily avoidable mistakes in the technical file that lead to immediate queries from regulators? Contact us at [email protected] or visit https://pureglobal.com/.